|
|
Bridge2AI: Voice as a Biomarker of Health - Building an ethically sourced, bioaccoustic database to understand disease like never before |
| 1OT2OD032720-01 |
|
OD |
2022 |
|
|
HIGH-DENSITY, MR-COMPATIBLE FUNCTIONAL NEAR-INFRARED SPECTROSCOPY SYSTEM FOR ADVANCING CLINICAL NEUROSCIENCE AND COGNITIVE BRAIN RESEARCH IN INFANTS, CHILDREN, ADOLESCENTS, AND ADULTS |
| 1S10OD026925-01 |
REISS, ALLAN L |
OD |
2019 |
|
|
DEVELOPMENT OF RESOURCES TO ASSESS AMBULATION AND SENSORY SYSTEMS FOR MARMOSET AD/DEMENTIA RESEARCH |
| 3P51OD011133-21S2 |
SCHLESINGER, LARRY S. |
OD |
2019 |
|
|
NOVEL MODELS OF ALZHEIMER'S DISEASE AND RELATED DISORDERS ENABLING SYSTEMATIC INVESTIGATION OF THE THERAPEUTIC POTENTIAL OF TRANSPLANTED HIPSC-DERIVED CELLS AND ENDOGENOUS ADULT NEURAL STEM CELLS |
| 3R01OD020376-04S1 |
MUMM, JEFFREY |
OD |
2019 |
|
|
DEVELOPMENT OF EPIDERMAL PROGENITOR CELL-BASED THERAPY FOR REGENERATIVE MEDICINE |
| 3R01OD023700-03S1 |
WU, XIAOYANG |
OD |
2019 |
|
|
DEVELOPMENT OF MARMOSET MODELS OF NEURODEGENERATIVE DISEASE USING EMBRYONIC STEM CELL-BASED GENE-EDITING APPROACHES |
| 3R24OD023076-03S1 |
LEE, KUO-FEN |
OD |
2019 |
|
|
DEVELOPMENT OF MARMOSET MODELS OF NEURODEGENERATIVE DISEASE USING EMBRYONIC STEM CELL-BASED GENE-EDITING APPROACHES |
| 5R24OD023076-03 |
LEE, KUO-FEN |
OD |
2019 |
|
|
AMYLOID BETA OLIGOMER INDUCTION OF ALZHEIMER'S DISEASE IN NONHUMAN PRIMATES |
| 3R43OD023025-01A1S1 |
WAKEMAN, DUSTIN ROBERT |
OD |
2018 |
|
|
DEVELOPMENT OF MARMOSET MODELS OF NEURODEGENERATIVE DISEASE USING EMBRYONIC STEM CELL-BASED GENE-EDITING APPROACHES |
| 5R24OD023076-02 |
LEE, KUO-FEN |
OD |
2018 |
|
|
DEVELOPMENT OF MARMOSET MODELS OF NEURODEGENERATIVE DISEASE USING EMBRYONIC STEM CELL-BASED GENE-EDITING APPROACHES |
| 1R24OD023076-01 |
LEE, KUO-FEN |
OD |
2017 |
